Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$16.8 - $20.99 $1.18 Million - $1.48 Million
-70,509 Reduced 23.97%
223,606 $3.79 Million
Q2 2023

Aug 14, 2023

BUY
$16.03 - $20.07 $1.25 Million - $1.56 Million
77,709 Added 35.91%
294,115 $5.9 Million
Q1 2023

May 15, 2023

BUY
$15.67 - $18.91 $568,930 - $686,565
36,307 Added 20.16%
216,406 $3.77 Million
Q4 2022

Feb 09, 2023

SELL
$13.5 - $17.14 $10.1 Million - $12.8 Million
-747,593 Reduced 80.59%
180,099 $2.79 Million
Q3 2022

Nov 14, 2022

BUY
$14.23 - $17.76 $7.03 Million - $8.77 Million
493,901 Added 113.86%
927,692 $14.2 Million
Q2 2022

Aug 12, 2022

BUY
$13.36 - $20.0 $5.8 Million - $8.68 Million
433,791 New
433,791 $6.61 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.3B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.